IWAL — what changed in the latest 10-Q
A section-by-section comparison of IWAL's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-15 vs the prior 10-Q · 2025-11-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +7 | −13 | ~10 | 18 |
| Controls & procedures | Text added/removed | +2 | −1 | ~1 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-15
Operating expenses, which consisted of general and administrative expenses, increased to $23,742 in the three months ended March 31, 2026, from $7,316 in the three months ended March 31, 2025, primarily as a result of an increase in auditor fees of $6,000, legal fees of $6,366 and rent expense of $8…
At March 31, 2026, we had $16 of cash on hand and an accumulated deficit of $6,729,118. Our primary source of liquidity during the three months ended March 31, 2026, has been from advances from a related party and bridge loans. As of March 31, 2026, the Company owed $14,720 in outstanding related pa…
Net cash used in operating activities was $5,212 during the three months ended March 31, 2026 and $19,132 during the three months ended March 31, 2025.
Net cash used in investing activities was $0 during the three months ended March 31, 2026 and 2025.
Net cash provided by financial activities was $5,228 and $20,000 during the three months ended March 31, 2026 and 2025.
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Operating expenses, which consisted of general and administrative expenses of $19,992 and research and development expenses of $161,882, increased to $181,874 in the three months ended September 30, 2025, from $7,678 in the three months ended September 30, 2024, primarily as a result of increased co…
Results of Operations for the nine months ended September 30, 2025, compared with the nine months ended September 30, 2024
We generated revenues of $0 during the nine months ended September 30, 2025 and 2024.
Operating expenses, which consisted of general and administrative expenses of $37,761 and research and development expenses of $171,582, increased to $209,343 in the nine months ended September 30, 2025, from $24,394 in the nine months ended September 30, 2024, primarily as a result of increased con…
We incurred interest expense of $36,113, during the nine months ended September 30, 2025, as compared to interest expense of $31,253 during the nine months ended September 30, 2024. Interest expense increased from the prior year because of the new notes added in the current period. The Company also …
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-15
The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Ac…
submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Compa…
Text removed vs the prior filing · source: 10-Q · 2025-11-13
The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Ac…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice